Prodotto aggiunto correttamente al carrello.

discount label
H-QASQEVKNW-OH
Visualizzare in 3D

Biosynth logo

H-QASQEVKNW-OH

Rif. 3D-PP44447

1mg
217,00 €
10mg
253,00 €
100mg
455,00 €
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024

Informazioni sul prodotto

Nome:
H-QASQEVKNW-OH
Sinonimi:
  • NH2-Gln-Ala-Ser-Gln-Glu-Val-Lys-Asn-Trp-OH
Descrizione:

Peptide H-QASQEVKNW-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-QASQEVKNW-OH include the following: Crystal structure of HLA-B*5801, a protective HLA allele for HIV-1 infection X Li , PA Lamothe , R Ng, S Xu, M Teng, BD Walker - Protein & , 2016 - academic.oup.comhttps://academic.oup.com/proteincell/article-abstract/7/10/761/6794493 Crystal structure of HLA-B* 5801 with a TW10 HIV Gag epitope reveals a novel mode of peptide presentation X Li , PA Lamothe , BD Walker , J Wang - Cellular & Molecular , 2017 - nature.comhttps://www.nature.com/articles/cmi201724 Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptide X Li , NK Singh , DR Collins , R Ng, A Zhang - Nature , 2023 - nature.comhttps://www.nature.com/articles/s41467-023-38573-8 Accurate modeling of peptide-MHC structures with AlphaFold V Mikhaylov , CA Brambley , GLJ Keller, AG Arbuiso - Structure, 2024 - cell.comhttps://www.cell.com/structure/pdf/S0969-2126(23)00413-6.pdf HLA-B57/B* 5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong T Miura, MA Brockman , A Schneidewind - Journal of , 2009 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02265-08 Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes T Beattie , R Kaul , T Rostron, T Dong , P Easterbrook - Aids, 2004 - journals.lww.comhttps://journals.lww.com/aidsonline/fulltext/2004/07230/screening_for_hiv_specific_t_cell_responses_using.15.aspx HLA B* 5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors SA Migueles, MS Sabbaghian - Proceedings of the , 2000 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.050567397 Pharmacogenetic testing for predicting at risk patients: Genotyping and flow cytometry of HLA-B S Mallal - Meeting of the American Association of , 2009 - researchportal.murdoch.edu.auhttps://researchportal.murdoch.edu.au/esploro/fulltext/conferencePresentation/Pharmacogenetic-testing-for-predicting-at-risk/991005540697707891?repId=12135273830007891&mId=13136826260007891&institution=61MUN_INST T cell epitope designing for dengue peptide vaccine using docking and molecular simulation studies S Krishnan , A Joshi , V Kaushik - Mol Simul, 2020 - researchgate.nethttps://www.researchgate.net/profile/Vikas-Kaushik-2/publication/341879480_T_cell_epitope_designing_for_dengue_peptide_vaccine_using_docking_and_molecular_simulation_studies/links/5ed7e3cf299bf1c67d35aa4b/T-cell-epitope-designing-for-dengue-peptide-vaccine-using-docking-and-molecular-simulation-studies.pdf Mechanisms of Recognition of HIV-Infected Cells by CD8+ T Cells that Mediate Effective Antiviral Responses PAL Molina - 2017 - search.proquest.comhttps://search.proquest.com/openview/5af23abe7541d2410cbf19508e805495/1?pq-origsite=gscholar&cbl=44156 Mechanisms of recognition of HIV-infected cells by CD8+ T cells that mediate effective antiviral responses PA Lamothe Molina - 2017 - dash.harvard.eduhttps://dash.harvard.edu/handle/1/40046512 Stephen A. Migueles, Alisha C. Laborico, Hiromi Imamichi M Connors , L Ehler, J Metcalf, S Liu, CW Hallahan - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=67afa30d3f6c874b0be2dda1711131c591eaa5bd The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes F Buseyne, Y Riviere - International immunology, 2001 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/13/7/941/785443 Characterization of an HIV-1 p24gag epitope recognized by a CD8+ cytotoxic T-cell clone F Buseyne, S Stevanovic, HG Rammensee , Y Riviacašre - Immunology letters, 1997 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247897026965 Patient-Specific Cytotoxic T-Lymphocyte Cross-Recognition of Naturally Occurring Variants of a Human Immunodeficiency Virus Type 1 (HIV-1) p24gagEpitope by F Buseyne, ML Chaix, C Rouzioux, S Blanche - Journal of , 2001 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.75.10.4941-4946.2001

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP44447 H-QASQEVKNW-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".